Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered
Lisata Therapeutics announced the termination of its licensing agreement with Qilu Pharmaceutical Co., Ltd. for...
Deals
WuXi Biologics Partners with Sinorda on SND006 Bispecific Antibody for Autoimmune Diseases
WuXi Biologics (HKG: 2269) announced a collaboration agreement with Guizhou Sinorda Biomedicineic Co., Ltd. to provide...
NeuShen Therapeutics Raises Series A+ for CNS Drug Development
NeuShen Therapeutics, a Sino‑US biotech focused on central nervous system (CNS) disorders, announced the completion...
Organon Completes $465M JADA System Sale to Laborie Medical
Organon (NYSE: OGN) announced the completed acquisition of its JADA system by Laborie Medical Technologies Corp....
Distinct Healthcare IPO Hong Kong: Private Provider Seeks $36M HKEX Listing
Distinct Healthcare Holdings Limited, a China‑based private healthcare service provider, released its prospectus this week...
Biogen’s Litifilimab Secures FDA Breakthrough Therapy Designation for Lupus
Biogen Inc. (NASDAQ: BIIB) announced that its investigational litifilimab has received Breakthrough Therapy Designation (BTD) from...
Seamless Therapeutics Partners with Eli Lilly on $1.12B Hearing Loss Recombinase Deal
Seamless Therapeutics, a Germany‑based gene editing company, announced a global strategic research collaboration and license...
Apeloa Partners with MindRank on AI Drug Development Platform
Apeloa Pharmaceutical Co., Ltd. (SHE: 000739), a China‑based contract development and manufacturing organization (CDMO), announced...
IVD Medical Launches Nipah Virus Detection Kit with AI Early Warning Platform
IVD Medical Holding Ltd (HKG: 1931), a China‑based in vitro diagnostic specialist, announced the launch...
Zhaoke Ophthalmology Expands BRIMOCHOL PF Presbyopia Distribution to Singapore and Vietnam
Zhaoke Ophthalmology (HKG: 6622) announced expanded distribution agreements for BRIMOCHOL PF to include Singapore and...
Acrobiosystems Files for Hong Kong IPO as Life Science Tools Leader
Acrobiosystems Co., Ltd. made its initial public offering filing to the Hong Kong Stock Exchange,...
Boehringer Ingelheim Licenses Simcere’s SIM0709 Bispecific for Inflammatory Bowel Disease
Boehringer Ingelheim and Simcere Pharmaceutical Group (HKG: 2096) announced a licensing and collaboration agreement to...
Sunshine Lake Pharma and Xtalpi Form AI Drug Discovery Joint Venture
Sunshine Lake Pharma Co., Ltd. (HKG: 6887) and Xtalpi Inc. (HKG: 2228) announced plans to...
HanchorBio Partners with WuXi Biologics on Next‑Gen Fusion Protein Manufacturing
HanchorBio, Inc. and WuXi Biologics (HKG: 2269) announced a strategic collaboration under which WuXi Biologics will...
Knature Biopharm Files Hong Kong IPO Backed by NAD+ Mitochondrial Platform
Knature Biopharmaceutical Co., Ltd. announced it has filed for an initial public offering (IPO) with...
GenEditBio Partners with uBriGene on LNP Ex Vivo Tech for Cell Therapy Manufacturing
GenEditBio announced a joint development agreement with uBriGene Biosciences International Co. to advance next‑generation lipid...
Merck Abandons $32 Billion Revolution Medicines Acquisition Over Price Dispute
Merck & Co. Inc. (MSD, NYSE: MRK) has reportedly ended acquisition talks with Revolution Medicines after the...
Dizal Pharmaceutical Files for Hong Kong IPO, Backed by AstraZeneca and First‑in‑Class Oncology Assets
Dizal Pharmaceutical Co., Ltd. (SHA: 688192), the China‑based joint venture established by AstraZeneca (AZ, NASDAQ: AZN)...
HealZen Inks Global DAC Partnership, Second TPD Deal Following J&J Alliance
Hangzhou HealZen Therapeutics Co., Ltd. announced a global partnership with an undisclosed American biotechnology company...